Share this page!

Enter URL or ID to Unroll

You can paste full URL like: https://x.com/threadreaderapp/status/1644127596119195649
or just the ID like: 1644127596119195649

How to get URL link on X (Twitter) App

  1. On the Twitter thread, click on or icon on the bottom
  2. Click again on or Share Via icon
  3. Click on Copy Link to Tweet
  4. Paste it above and click "Unroll Thread"!
  5. More info at Twitter Help
David van Duin Profile picture
David van Duin
@davidvanduin
Infectious Diseases doc with interests in multi-drug resistant Gram-negative bacteria, and transplant, hem/onc, and burn patients. Opinions are my own.
Dec 17, 2021 • 17 tweets • 10 min read
1/n
 comparing @ESCMID MDR GNR guidelines vs. @IDSAInfo guidance

let's tackle CRE next
note:
-@IDSAInfo is a "guidance" document not a guideline & focused on US practice
-recs paraphrased as needed

@jesusrbano @ClancyNeil @OncIDPharmd @ABsteward 2/n @ESCMID: For patients with severe infections due to CRE, we suggest mero-vabor or ceftaz-avi
@IDSAInfo: Ceftaz-avi, mero-vabor, and imi-rel are preferred options for infections outside of the urinary tract caused by CRE when carbapenemase results are not available or neg.
Dec 16, 2021 • 21 tweets • 11 min read
1/n @ESCMID guidelines are wonderful resource for clinicians treating MDR GNR infections. Great work @jesusrbano @EveTacconelli and many others!
let's compare to @IDSAInfo guidance (paraphrased recs prn). starting w/ 3GcephR-E
idsociety.org/practice-guide… &
idsociety.org/practice-guide… 2/n
 First, @IDSAInfo AMR guidance is explicitly "guidance" not a guideline.
Second, @IDSAinfo focuses on treatment recommendations for antimicrobial resistant infections in the United States.